How to Interpret the Use of Proceeds Section in a Prospectus: Strategic Signals for Investors

The SEC’s Division of Corporation Finance issued Staff Legal Bulletin No. 14M (CF Disclosure Guidance: Topic 9) in December 2024, explicitly expanding its scrutiny of the Use of Proceeds section in registration statements under the Securities Act of 1933. The bulletin directs staff to request more granular disclosure on the allocation of proceeds to specific working capital components, particularly when the issuer’s business model involves material capital expenditure commitments or contingent liabilities. This shift is not merely procedural. For investors parsing the S-1 or F-1 of a China-based issuer listing on the NYSE or NASDAQ, the Use of Proceeds section has become a primary signal of management’s capital allocation strategy, its exposure to PRC regulatory risk, and the likely timeline for deploying raised funds. In the current 2025-2026 cycle, where cross-border IPO volumes from Asia-Pacific issuers have rebounded 42% year-on-year to USD 18.7 billion (Bloomberg, Q1 2026 data), misreading this section can lead to mispriced entry points. This article dissects the mechanics of the Use of Proceeds section, translating its boilerplate into actionable strategic signals for CFOs, IBD analysts, and family office principals.

The Structural Anatomy of Use of Proceeds: Beyond Boilerplate

The Use of Proceeds section is not a standalone narrative. It is a forward-looking financial statement that must reconcile with the issuer’s capitalisation table, the proceeds from the offering, and the liquidity projections in the MD&A. Under Item 504 of SEC Regulation S-K, an issuer must state the principal purposes for which the net proceeds are intended and the approximate amount intended for each purpose. For foreign private issuers filing on Form F-1, the requirement is identical under General Instruction C. The strategic signal lies in the specificity of the categories.

Working Capital vs. Acquisition: The Capital Allocation Signal

The most critical distinction is between proceeds allocated to “general working capital” and those earmarked for “acquisitions” or “capital expenditures.” A 2023 study by the Harvard Law School Forum on Corporate Governance found that issuers allocating more than 60% of net proceeds to general working capital exhibited a 14% lower median one-year post-IPO return compared to issuers specifying allocation to R&D or capex. For Hong Kong-based issuers listing in the US, this pattern holds even more strongly. A 2025 analysis of 12 China ADR IPOs on NASDAQ showed that the three issuers allocating over 70% of net proceeds to “strategic acquisitions” underperformed the NASDAQ Composite by an average of 18.5% over six months, while the two issuers allocating over 50% to “R&D and product development” outperformed by 12.3%. The signal is clear: vague working capital allocation often indicates management lacks a specific deployment plan, which correlates with weaker post-listing execution.

The “To Be Determined” Trap and Redemption Risk

A common but dangerous phrase in prospectuses is “the specific allocation of net proceeds has not been determined.” Under SEC Staff Legal Bulletin No. 14M, this language now triggers a mandatory request for a more detailed breakdown. For SPAC de-SPAC transactions, the issue is acute. The SEC’s 2024 SPAC Rule (Release No. 33-11248) requires that the Use of Proceeds section in a de-SPAC proxy statement must explicitly state the amount of cash held in trust that will be used for the business combination, and the amount that will be returned to redeeming shareholders. If the target company’s prospectus states that proceeds will be used for “general corporate purposes” without quantifying the trust drawdown, the SEC staff will issue a deficiency letter. For investors, an issuer that avoids specificity in this section is signalling either weak financial planning or an intention to use proceeds for share buybacks or management bonuses, which are not typically disclosed until the first post-IPO annual report.

Reading the Regulatory Cues: PRC Issuers and the 2025 CSRC Filing Regime

For issuers domiciled in the PRC, Hong Kong, or with significant PRC operations, the Use of Proceeds section has become a de facto compliance document under the CSRC’s revised Rules for Overseas Securities Offering and Listing (effective 1 January 2025). The CSRC now requires that the prospectus for any overseas listing (including US exchanges) must include a specific statement on the intended use of proceeds in the PRC, including any plans to repatriate funds.

The Repatriation Clause and FX Risk Disclosure

A 2025 HKMA circular (Ref: C10/2025) reminded authorised institutions that cross-border capital flows from US-listed PRC companies must comply with the State Administration of Foreign Exchange (SAFE) Circular 37 regulations. The Use of Proceeds section for a PRC-based issuer must therefore include a statement on the intended use of proceeds within the PRC and the mechanism for converting USD to RMB. For example, in the F-1 of Horizon Robotics (filed March 2025), the issuer allocated 35% of net proceeds to “R&D in the PRC” with a specific note that “the Company intends to repatriate approximately USD 150 million through its onshore subsidiary, subject to SAFE registration.” Issuers that omit this language face a higher probability of CSRC rejection or a delayed effective date. For investors, the presence of a detailed repatriation plan signals that the issuer’s legal counsel has completed the required PRC regulatory filings, reducing the risk of a post-IPO capital freeze.

The VIE Structure and Contingent Proceeds

For issuers using a Variable Interest Entity (VIE) structure, the Use of Proceeds section must address the flow of funds through the offshore holding company (typically a Cayman Islands entity) to the PRC operating entity. The SEC’s 2021 VIE disclosure guidance (CF Disclosure Guidance: Topic 9A) requires that the prospectus state whether the proceeds will be used to fund the VIE or its onshore subsidiaries. A 2025 review of 18 China ADR F-1 filings by the US Listing Desk found that 14 included a statement that “proceeds will be used primarily to fund the operations of the PRC subsidiaries through intercompany loans or capital contributions.” The remaining four, which did not include this language, all received SEC comment letters requesting clarification. For analysts, the absence of a VIE-specific Use of Proceeds clause is a red flag that the issuer’s corporate structure may not be fully compliant with PRC foreign investment restrictions.

Strategic Signals in De-SPAC Transactions

The de-SPAC transaction presents a unique Use of Proceeds dynamic because the proceeds are not solely from the IPO. The trust account contains the SPAC’s IPO proceeds, plus any interest earned, minus redemptions. The de-SPAC proxy statement must reconcile these sources.

The Trust Drawdown and Earnout Structure

Under the SEC’s 2024 SPAC Rule, the Use of Proceeds section in the de-SPAC proxy must disclose the exact amount of trust proceeds that will be drawn down for the business combination, and the amount that will be used for earnout payments to the SPAC sponsor or target shareholders. A 2025 study by the University of Chicago Booth School of Business found that de-SPAC transactions where the Use of Proceeds disclosed a trust drawdown of less than 60% of the trust value had a median 12-month post-combination return of -23.4%, compared to +4.1% for those drawing down over 80%. The reason is that a low drawdown signals that the target company is not receiving sufficient cash to execute its business plan, often because redemptions were high. For family office principals evaluating a de-SPAC target, the ratio of trust drawdown to total proceeds is a direct measure of the deal’s cash quality.

The Working Capital Minimum and the PIPE

The de-SPAC prospectus must also state whether the proceeds will be used to meet the minimum cash condition (often USD 5 million to USD 50 million) required for the business combination to close. If the Use of Proceeds section allocates a specific amount to “meeting the minimum cash condition,” it is a strong signal that the PIPE (Private Investment in Public Equity) was undersubscribed. Conversely, if the section states that proceeds will be used for “growth initiatives” without referencing the cash condition, the PIPE is likely fully committed. For IBD analysts, this distinction is critical for modelling post-combination liquidity. A 2025 analysis of 22 de-SPAC transactions on NASDAQ showed that the five deals that explicitly allocated proceeds to the minimum cash condition had a median cash burn rate of USD 1.2 million per month post-combination, compared to USD 0.4 million for those that did not.

Practical Takeaways for Investors

The Use of Proceeds section is not a static disclosure. It is a dynamic map of management’s capital allocation intent, regulatory compliance posture, and deal quality. For investors, the following five signals are actionable:

1. Specificity correlates with execution. Issuers allocating more than 50% of net proceeds to named projects (R&D, capex, acquisitions) outperform those allocating over 60% to general working capital by an average of 14% over 12 months (Harvard Law School Forum, 2023).
2. PRC issuers must include a repatriation clause. The absence of a SAFE-compliant repatriation plan in the Use of Proceeds section increases the probability of a CSRC rejection or a post-IPO capital freeze by an estimated 30% based on 2025 filing data.
3. De-SPAC trust drawdown below 60% signals cash starvation. A low drawdown ratio is the single strongest negative predictor of post-combination stock performance, with a median return of -23.4% at 12 months (University of Chicago, 2025).
4. The “to be determined” language is a regulatory risk. Under SEC Staff Legal Bulletin No. 14M, vague allocation language triggers comment letters, delaying the effective date by an average of 45 days.
5. VIE structure disclosure is non-negotiable. For any China ADR issuer, the Use of Proceeds section must explicitly state the flow of funds through the VIE structure. Omission is a red flag for SEC enforcement risk.